Edition:
United States

Paion AG (PA8G.DE)

PA8G.DE on Xetra

2.15EUR
11:36am EDT
Change (% chg)

€0.00 (+0.00%)
Prev Close
€2.15
Open
€2.15
Day's High
€2.18
Day's Low
€2.14
Volume
28,483
Avg. Vol
49,502
52-wk High
€2.85
52-wk Low
€2.01

Chart for

About

Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In... (more)

Overall

Beta: 0.62
Market Cap(Mil.): €149.43
Shares Outstanding(Mil.): 63.86
Dividend: --
Yield (%): --

Financials

  PA8G.DE Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.20 -- --
ROI: -52.48 1.96 12.83
ROE: -52.48 1.12 14.95

Earnings vs. Estimates